YARAL is the US generics subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. Committed to advancing healthcare through high-quality authorized generics (AGs) and complex generic medicines, YARAL delivers exceptional value with a focus on patient outcomes, reliable supply, and personalized customer service. The company brings a bold, human centered approach to the US.